Announcements Trials
Browse Landscape

Phase

Phase NA 51Phase 3 29Phase 2 28Phase 1 19Phase 1/2 12Phase 2/3 4Phase 4 2Phase EARLY_PHASE1 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Head & Neck 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Breast Neoplasms 9Prostatic Neoplasms 5Neoplasms 5Multiple Myeloma 5Neoplasm Metastasis 3Leukemia, Myeloid, Acute 3Leiomyoma 3Carcinoma, Non-Small-Cell Lung 3Lung Neoplasms 2Hematologic Neoplasms 2Glioma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Vomiting 1Venous Thromboembolism 1Tuberous Sclerosis 1Thyroid Neoplasms 1Thyroid Diseases 1Thoracic Neoplasms 1Thalassemia 1Squamous Cell Carcinoma of Head and Neck 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pulmonary Embolism 1Primary Myelofibrosis 1Post-operative Seroma Formation 1Polycythemia Vera 1Pituitary Neoplasms 1Pelvic Pain 1

Interventions

Specimen Handling 1Immune Checkpoint Inhibitors 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Lung Neoplasms × 30 days × Clear all
NCT07279935 2026-06-01

REVIVE

AstraZeneca

Phase 4 Recruiting
100 enrolled
Thoracic

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

OHSU Knight Cancer Institute

Phase 4 Recruiting
160 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡